Clinical Trial Update: Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects [Phase 1]

View source ↗

Summary

A Phase 1 PK/PD study of rivaroxaban in pediatric patients with venous thromboembolism has completed, providing initial pharmacokinetic and pharmacodynamic data…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thrombosis, Pediatrics | Phase 1 | Status: COMPLETED